Defining "platinum-ineligible" patients with metastatic urothelial cancer (mUC).

被引：23

作者：

Gupta, Shilpa

Sonpavde, Guru

Grivas, Petros

Apolo, Andrea B.

Plimack, Elizabeth R.

Flaig, Thomas W.

Hahn, Noah M.

Balar, Arjun Vasant

Bajorin, Dean F.

Galsky, Matt D.

Rosenberg, Jonathan E.

机构：

[1] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA

[2] Dana Farber Canc Inst, Dept Genitourinary Oncol, Boston, MA 02115 USA

[3] Univ Washington, Seattle, WA 98195 USA

[4] NCI, Genitourinary Malignancies Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA

[5] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA

[6] Univ Colorado, Ctr Comprehens Canc, Aurora, CO USA

[7] Johns Hopkins Univ, Sch Med, Baltimore, MD USA

[8] NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY USA

[9] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[10] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA

来源：

关键词：

D O I：

10.1200/JCO.2019.37.7_suppl.451

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

451

引用

页数：3